203 related articles for article (PubMed ID: 32611328)
21. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.
Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA
J Gen Intern Med; 2016 Oct; 31(10):1190-7. PubMed ID: 27279097
[TBL] [Abstract][Full Text] [Related]
22. Similar fecal immunochemical test results in screening and referral colorectal cancer.
van Turenhout ST; van Rossum LG; Oort FA; Laheij RJ; van Rijn AF; Terhaar sive Droste JS; Fockens P; van der Hulst RW; Bouman AA; Jansen JB; Meijer GA; Dekker E; Mulder CJ
World J Gastroenterol; 2012 Oct; 18(38):5397-403. PubMed ID: 23082056
[TBL] [Abstract][Full Text] [Related]
23. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
[TBL] [Abstract][Full Text] [Related]
25. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
[TBL] [Abstract][Full Text] [Related]
26. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
28. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia.
Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS
Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186
[TBL] [Abstract][Full Text] [Related]
29. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
[TBL] [Abstract][Full Text] [Related]
30. Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests.
Symonds EL; Pedersen S; Cole SR; Massolino J; Byrne D; Guy J; Backhouse P; Fraser RJ; LaPointe L; Young GP
Asian Pac J Cancer Prev; 2015; 16(18):8455-60. PubMed ID: 26745101
[TBL] [Abstract][Full Text] [Related]
31. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
32. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
[TBL] [Abstract][Full Text] [Related]
33. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.
Corley DA; Jensen CD; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Schottinger JE; Marks AR; Zhao WK; Ghai NR; Lee AT; Contreras R; Quesenberry CP; Fireman BH; Levin TR
JAMA; 2017 Apr; 317(16):1631-1641. PubMed ID: 28444278
[TBL] [Abstract][Full Text] [Related]
34. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey.
Banaszkiewicz Z; Budzyński J; Tojek K; Jarmocik P; Frasz J; Mrozowski M; Świtoński M; Jawień A
Adv Med Sci; 2017 Mar; 62(1):171-176. PubMed ID: 28282604
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
36. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
37. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
[TBL] [Abstract][Full Text] [Related]
38. Attitudes towards faecal immunochemical testing in patients at increased risk of colorectal cancer: an online survey of GPs in England.
von Wagner C; Stoffel S; Freeman M; Laszlo H; Nicholson BD; Sheringham J; Szinay D; Hirst Y
Br J Gen Pract; 2018 Nov; 68(676):e757-e764. PubMed ID: 30297435
[TBL] [Abstract][Full Text] [Related]
39. Time to fecal immunochemical test completion for colorectal cancer screening.
Haas CB; Phipps AI; Hajat A; Chubak J; Wernli KJ
Am J Manag Care; 2019 Apr; 25(4):174-180. PubMed ID: 30986014
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program.
Brezina S; Leeb G; Baierl A; Gräf E; Hackl M; Hofer P; Lang H; Klein M; Mach K; Schwarzer R; Wlassits W; Püspök A; Gsur A
BMC Gastroenterol; 2024 Apr; 24(1):149. PubMed ID: 38689217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]